Rabecan Duo Tablet 20/700 mg (Rabeprazole Sodium, Sodium Bicarbonate)

Adult dose

The usual adult dosage is 10/700 mg orally once a day. Depending on symptoms, 20/700 mg may be administered orally once a day. Generally, for gastric ulcers, treatment lasts up to 8 weeks; for duodenal ulcers, up to 6 weeks. For erosive or ulcerative gastroesophageal reflux disease: 10/700 mg or 20/700 mg should be administered orally once daily for 4 to 8 weeks. If not resolved after 8 weeks, an additional 8-week treatment with 10/700 mg or 20/700 mg may be considered.

Child dose

Safety in pediatric patients has not been established.

This medication contains Rabeprazole Sodium and Sodium Bicarbonate, and should be avoided in certain patients. Patients allergic to Rabeprazole or benzimidazole derivatives, those taking Atazanavir or Rilpivirine, and pregnant or breastfeeding women should not use this medication. Patients with poor liver or kidney function, the elderly, those with heart or lung issues, and patients with electrolyte imbalances should use this medication with caution. This medication contains Yellow No. 4 (Tartrazine), so individuals allergic to this component should also exercise caution. Various side effects may occur during use, including skin rashes, itching, blood abnormalities, liver function abnormalities, cardiovascular issues, gastrointestinal symptoms, neurological issues, respiratory problems, musculoskeletal pain, and urological issues. If symptoms appear, consult a doctor immediately. Regular blood tests and liver function tests are required during long-term use, and consultation with a specialist is recommended if symptoms suspicious of gastric ulcers or gastric cancer occur. As this medication inhibits gastric acid secretion, it may affect the absorption of certain drugs; consult a specialist when used in combination with other medications. Pregnant or breastfeeding women should not take this medication, and caution is advised for the elderly due to the higher risk of side effects related to decreased liver function. Safety in pediatric patients has not been established, so it is best to avoid use. In cases of overdose, there is no specific antidote, so treatment and supportive care based on symptoms are necessary. This medication should be stored out of reach of children and not transferred to other containers for safety. Drowsiness may occur when driving or operating machinery, thus caution is necessary. Long-term use carries risks of osteoporosis and hypomagnesemia; regular monitoring is needed. Lastly, autoimmune disease symptoms such as skin or systemic lupus erythematosus may appear while taking this medication, so report any abnormal symptoms to healthcare professionals immediately.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, oral or ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and intense headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Rash
• itching
• decreased red blood cells
• decreased white blood cells
• increased white blood cells
• increased eosinophils
• increased neutrophils
• decreased lymphocytes
• anemia
• purpura

This medication should be stored in a closed container to prevent exposure to air or moisture, and it is important to maintain a storage temperature between 1 and 30 degrees Celsius. Storing it this way helps preserve the effectiveness of the medication for a long time.

Appearance

Pale pink oval film-coated tablet

Package unit

28 tablets per bottle